| Product Code: ETC9690520 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Nucleic Acid-Based Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Nucleic Acid-Based Therapeutics Market - Industry Life Cycle |
3.4 Thailand Nucleic Acid-Based Therapeutics Market - Porter's Five Forces |
3.5 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.8 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Thailand Nucleic Acid-Based Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Thailand |
4.2.2 Growing investment in healthcare infrastructure and research development |
4.2.3 Rising adoption of personalized medicine in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for nucleic acid-based therapeutics |
4.3.2 High cost associated with development and production of nucleic acid-based therapies |
4.3.3 Limited awareness and understanding of nucleic acid-based therapeutics among healthcare providers and patients |
5 Thailand Nucleic Acid-Based Therapeutics Market Trends |
6 Thailand Nucleic Acid-Based Therapeutics Market, By Types |
6.1 Thailand Nucleic Acid-Based Therapeutics Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Monogenic Disorders, 2021- 2031F |
6.1.4 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Multigenic Disorders, 2021- 2031F |
6.2 Thailand Nucleic Acid-Based Therapeutics Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Single Stranded RNA/DNA, 2021- 2031F |
6.2.3 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Double Stranded DNA, 2021- 2031F |
6.3 Thailand Nucleic Acid-Based Therapeutics Market, By Technologies |
6.3.1 Overview and Analysis |
6.3.2 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Anti-Sense Technology, 2021- 2031F |
6.3.3 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By RNA and DNA Therapy, 2021- 2031F |
6.3.5 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Aptamers,, 2021- 2031F |
6.3.6 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Nucleoside Analogs, 2021- 2031F |
6.3.7 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Nucleic Acid-Based Therapeutics Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.4 Thailand Nucleic Acid-Based Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Nucleic Acid-Based Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand Nucleic Acid-Based Therapeutics Market Export to Major Countries |
7.2 Thailand Nucleic Acid-Based Therapeutics Market Imports from Major Countries |
8 Thailand Nucleic Acid-Based Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for nucleic acid-based therapeutics in Thailand |
8.2 Government funding allocated to support research and development in the field of nucleic acid-based therapeutics |
8.3 Number of partnerships and collaborations between local and international biopharmaceutical companies for nucleic acid-based therapeutics in Thailand |
9 Thailand Nucleic Acid-Based Therapeutics Market - Opportunity Assessment |
9.1 Thailand Nucleic Acid-Based Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Thailand Nucleic Acid-Based Therapeutics Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 Thailand Nucleic Acid-Based Therapeutics Market Opportunity Assessment, By Technologies, 2021 & 2031F |
9.4 Thailand Nucleic Acid-Based Therapeutics Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Thailand Nucleic Acid-Based Therapeutics Market - Competitive Landscape |
10.1 Thailand Nucleic Acid-Based Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Nucleic Acid-Based Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here